There are 15,358 results relating to "Medicin Viagra-m"
Order by
|
Questions and Answers
Date answered:
26 August 2003
S2W-01639
To enable new types of prescriber to prescribe prescription only medicines would require amendment of the Prescription Only Medicines (Human Use) Order 1997.
Questions and Answers
Date answered:
3 January 2002
S1W-20723
Requirements for the provision of drug information leaflets to patients are reserved matters which come under the remit of the Medicines Control Agency. Directive 92/27/EEC was incorporated into UK law by the Medicines (Marketing Authorisations etc) Regulations 1994 and the Scottish Executive supports its aim of ensu...
Questions and Answers
Date answered:
8 May 2000
S1W-05323
An action plan is already in place to address pressures on oral medicine. On 30 March, the Trust Board approved the appointment of an additional Consultant which should lead to considerable improvement in the waiting times for oral medicine over the next 12 months.Currently, one Dental Practitioner is operating two a...
Questions and Answers
Date answered:
16 May 2002
S1W-24752
This details the Executive's planned spend on repairs, routine and winter maintenance, and PPP payments relating to the M74/A74(M) contract through the current three-year period.
Questions and Answers
Date answered:
27 February 2007
S2W-31833
To ask the Scottish Executive whether Coproxamol will continue to be obtainable on prescription in Scotland. Licensing of medicines is reservedand is the responsibility of the Medicines and Healthcare products Regulatory Agency.The agency has advised that Coproxamolis being phased out of the market gradually to give...
Questions and Answers
Date answered:
5 December 2006
S2W-30119
To ask the Scottish Executive what plans it has to include prescribing rates of new treatments for psoriatic arthritis in its programme of public annual reviews of local NHS boards. The Scottish Medicines Consortium(SMC) conducts rapid assessments soon after their launch of the costs and benefitsof medicines such as etanercept, an anti-tumour necrosis factor drug, which hasbeen shown in clinical trials to offer a new option for people with psoriatic arthritis.NHSScotland is expected to take account of the advice from the SMC and ensure thatrecommended medicines are made available to meet clinical need.The agendas for NHS boards’ annualreviews are set by me as Minister for Health and Community Care, taking accountof key health care issues of national and local importance and the overall progressof individual boards.
Questions and Answers
Date answered:
27 June 2003
S2W-00713
To ask the Scottish Executive what plans there are to withdraw the use of seroxat as an anti-depressant for those under 18. The regulation of medicines is a reserved matter and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA).New data from clinical trials of Seroxat in childre...
Questions and Answers
Date answered:
11 December 2001
S1W-20419
In addition, some new medicines will be evaluated by the Health Technology Board for Scotland.
Questions and Answers
Date answered:
7 July 2000
S1W-08229
The Medicines Control Agency investigates any reports of the unlicensed manufacture, promotion and sale of gamma-hydroxybutyrate in the UK.
Questions and Answers
Date answered:
3 December 1999
S1W-02690
It is for each Health Board to determine its prescribing policy on medicines, including Riluzole, taking into account the advice provided by their Drug and Therapeutic Committee.In 1996, Riluzole was granted a Marketing Authorisation valid for the European Union on the basis of the dossier submitted to the European Medicines Evaluation Agency (EMEA).
